Susquehanna International Group
KRSA

Susquehanna International Group’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Susquehanna International Group’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-323
Closed -$11.7K – 12222
2023
Q1 		$19.6K Buy
323
+187
+138% +$2.36K ﹤0.01% 12059
2022
Q4 		$12.5K Sell
136
-55
-29% -$651 ﹤0.01% 11894
2022
Q3 		$23K Sell
191
-37
-16% -$636 ﹤0.01% 12548
2022
Q2 		$18K Buy
228
+86
+61% +$1.23K ﹤0.01% 12390
2022
Q1 		$22K Sell
142
-57
-29% -$1.37K ﹤0.01% 12597
2021
Q4 		$48K Sell
199
-196
-50% -$9.26K ﹤0.01% 12566
2021
Q3 		$170K Sell
395
-178
-31% -$11.7K ﹤0.01% 11664
2021
Q2 		$313K Buy
573
+376
+191% +$23.5K ﹤0.01% 10690
2021
Q1 		$77K Buy
197
+40
+25% +$3K ﹤0.01% 11943
2020
Q4 		$67K Buy
157
+80
+104% +$5.45K ﹤0.01% 10664
2020
Q3 		$66K Buy
+77
New +$8.8K ﹤0.01% 10111
2020
Q1 		– Sell
-130
Closed -$50K – 10315
2019
Q4 		$50K Buy
130
+55
+73% +$5.14K ﹤0.01% 9343
2019
Q3 		$128K Sell
75
-9
-11% -$1.94K ﹤0.01% 9422
2019
Q2 		$135K Buy
+84
New +$23.8K ﹤0.01% 9446

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Susquehanna International Group's KRSA Position: Q2 2023 in Review

Susquehanna International Group sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2023, closing a stake of 323 shares — an estimated $11.7K sold.

Susquehanna International Group first reported a position in KRSA in Q2 2019 and held it in 14 quarters. The position peaked at $313K in Q2 2021. 17 funds tracked by Wall St. Rank hold KRSA as of Q2 2023.

  • Susquehanna International Group reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 323 Korsana Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $11.7K.
  • Susquehanna International Group first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Susquehanna International Group's Korsana Biosciences, Inc. Common Stock position peaked at $313K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.